Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.5K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.5K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
Autoimmune Disorders01:29

Autoimmune Disorders

1.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.4K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of cancer and immunosuppression in pneumocystis pneumonia: a large comprehensive population-based study.

Infection·2026
Same author

[Modern knowledge transfer in rheumatology-From the perspective of teachers].

Zeitschrift fur Rheumatologie·2026
Same author

The Impact of Operator Access on Implant Surface Roughness Following Implantoplasty Procedures: A Laboratory Study.

Clinical and experimental dental research·2026
Same author

Zeitschrift fur Rheumatologie·2026
Same author

Latent Causal Diffusions for Single-Cell Perturbation Modeling.

ArXiv·2026
Same author

Sex-Specific Phenotypes and Outcomes in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease: Results from the INSIGHTS-ILD Registry.

Respiration; international review of thoracic diseases·2026
Same journal

The Prevalence of Hospitalized Cases of Necrotizing Fasciitis: Anatomical Distribution, Amputations, and In-Hospital Mortality, 2019-2024.

Deutsches Arzteblatt international·2026
Same journal

Subclinical Atrial Fibrillation: Detection, Stroke Risk, and Treatment.

Deutsches Arzteblatt international·2026
Same journal

Fewer Premature Births After Assisted Reproduction.

Deutsches Arzteblatt international·2026
Same journal

Femoral Artery Pseudoaneurysm Due to Stent Fracture in PAOD.

Deutsches Arzteblatt international·2026
Same journal

Pain-Adapted Full Weight-bearing After Ankle Fracture Surgery: A Multicenter, Pragmatic, Single-armed Prospective Study.

Deutsches Arzteblatt international·2026
Same journal

Popliteal Artery Entrapment Syndrome.

Deutsches Arzteblatt international·2026
See all related articles

Related Experiment Video

Updated: Jan 6, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

8.1K

Pulmonary Involvement in Autoimmune-Mediated Disease.

Tobias Hoffmann, Martin Aringer, Dirk Koschel

    Deutsches Arzteblatt International
    |September 24, 2025
    PubMed
    Summary
    This summary is machine-generated.

    Interstitial lung disease (ILD) is a significant complication of autoimmune diseases (AID), affecting up to 50% of patients. Early detection and treatment of ILD are crucial for improving patient outcomes.

    More Related Videos

    Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
    10:21

    Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

    Published on: September 20, 2024

    704
    Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
    06:15

    Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

    Published on: November 10, 2023

    1.4K

    Related Experiment Videos

    Last Updated: Jan 6, 2026

    Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
    10:39

    Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

    Published on: April 16, 2019

    8.1K
    Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
    10:21

    Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

    Published on: September 20, 2024

    704
    Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
    06:15

    Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

    Published on: November 10, 2023

    1.4K

    Area of Science:

    • Rheumatology
    • Pulmonology
    • Immunology

    Background:

    • Interstitial lung disease (ILD) is a key manifestation in various autoimmune diseases (AID).
    • Management strategies for ILD across different AID types are crucial.

    Purpose of the Study:

    • To review the management of interstitial lung disease (ILD) in patients with autoimmune diseases (AID).

    Main Methods:

    • Comprehensive literature search of PubMed, focusing on meta-analyses and RCTs.
    • Inclusion of guidelines, expert consensus, and clinical experience.

    Main Results:

    • ILD prevalence varies widely (7-50%) in rheumatic diseases; less common in organ-specific AID.
    • Progressive fibrosing course occurs in 16-40% of ILD cases.
    • Early diagnosis via PFTs and HRCT is recommended, with regular screening for high-prevalence AID.

    Conclusions:

    • ILD is a critical manifestation of systemic autoimmune and inflammatory rheumatic diseases.
    • Early recognition and targeted pharmacotherapy, including antifibrotics for progressive fibrosis, improve clinical outcomes.
    • Interdisciplinary management and considering the underlying disease prognosis are essential.